School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, PR China.
The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, PR China.
Medicine (Baltimore). 2024 Apr 19;103(16):e37844. doi: 10.1097/MD.0000000000037844.
Diabetes mellitus (DM) is one of the most prevalent diseases worldwide, greatly impacting patients' quality of life. This article reviews the progress in Salvia miltiorrhiza, an ancient Chinese plant, for the treatment of DM and its associated complications. Extensive studies have been conducted on the chemical composition and pharmacological effects of S miltiorrhiza, including its anti-inflammatory and antioxidant activities. It has demonstrated potential in preventing and treating diabetes and its consequences by improving peripheral nerve function and increasing retinal thickness in diabetic individuals. Moreover, S miltiorrhiza has shown effectiveness when used in conjunction with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers (ARBs), and statins. The safety and tolerability of S miltiorrhiza have also been thoroughly investigated. Despite the established benefits of managing DM and its complications, further research is needed to determine appropriate usage, dosage, long-term health benefits, and safety.
糖尿病(DM)是全球最常见的疾病之一,极大地影响了患者的生活质量。本文综述了丹参这一中国传统植物在治疗糖尿病及其相关并发症方面的研究进展。丹参的化学成分和药理作用,包括其抗炎和抗氧化活性,已经进行了广泛的研究。它通过改善糖尿病患者的周围神经功能和增加视网膜厚度,显示出在预防和治疗糖尿病及其后果方面的潜力。此外,丹参与血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂(ARBs)和他汀类药物联合使用也具有疗效。丹参的安全性和耐受性也得到了充分的研究。尽管在管理糖尿病及其并发症方面已经取得了明确的益处,但仍需要进一步的研究来确定其适当的使用、剂量、长期健康益处和安全性。